HPV status and favorable outcome in vulvar squamous cancer

Katie Wakeham, Kim Kavanagh, Kate Cuschieri, David Millan, Kevin G Pollock, Sarah Bell, Kevin Burton, Nick Reed, Sheila V Graham

Research output: Contribution to journalArticle

23 Downloads (Pure)

Abstract

It is universally accepted that high-risk human papillomavirus (HR-HPV) is the cause of cervical dysplasia and cancer. More recently it has been shown that HPV is also a marker of clinical outcome in oropharyngeal cancer. However, contemporary information is lacking on both the prevalence of HPV infection in vulvar cancer (VSCC), its precursor lesion, vulvar intraepithelial neoplasia (VIN) and the influence of HPV-status on the prognosis of this malignancy. We have conducted a detailed population-based study to examine rates of progression of VIN to VSCC, type-specific HPV prevalence in vulvar disease and the influence of HPV status on clinical outcome in VSCC. We observed that the age at which women are diagnosed with VSCC is falling and there is a significant time gap between first diagnosis of VIN and progression to invasive disease. HR-HPV infection was detected in 87% (97/112) cases of VIN and 52% cases (32/62) of VSCC. The presence of HR-HPV in squamous intraepithelial lesion was associated with lower rates of progression to invasive cancer (hazard ratio, 0.22, p=0.001). In the adjusted analysis, HR-HPV was associated with improved progression-free survival of VSCC compared to those with HPV negative tumours (hazard ratio, 0.32, p=0.02).
Original languageEnglish
Pages (from-to)1-35
Number of pages35
JournalInternational Journal of Cancer
Publication statusAccepted/In press - 7 Oct 2016

Fingerprint

Vulvar Neoplasms
Neoplasms
Vulvar Diseases
Accidental Falls
Uterine Cervical Dysplasia
Oropharyngeal Neoplasms
Papillomavirus Infections
Uterine Cervical Neoplasms
Disease-Free Survival
Biomarkers
Infection

Keywords

  • HPV
  • human papillomavirus
  • vulvar intraepithelial neoplasia
  • vulvar cancer

Cite this

Wakeham, K., Kavanagh, K., Cuschieri, K., Millan, D., Pollock, K. G., Bell, S., ... Graham, S. V. (Accepted/In press). HPV status and favorable outcome in vulvar squamous cancer. International Journal of Cancer, 1-35.
Wakeham, Katie ; Kavanagh, Kim ; Cuschieri, Kate ; Millan, David ; Pollock, Kevin G ; Bell, Sarah ; Burton, Kevin ; Reed, Nick ; Graham, Sheila V. / HPV status and favorable outcome in vulvar squamous cancer. In: International Journal of Cancer. 2016 ; pp. 1-35.
@article{727666186eb34f06b34e7cd0d54323b8,
title = "HPV status and favorable outcome in vulvar squamous cancer",
abstract = "It is universally accepted that high-risk human papillomavirus (HR-HPV) is the cause of cervical dysplasia and cancer. More recently it has been shown that HPV is also a marker of clinical outcome in oropharyngeal cancer. However, contemporary information is lacking on both the prevalence of HPV infection in vulvar cancer (VSCC), its precursor lesion, vulvar intraepithelial neoplasia (VIN) and the influence of HPV-status on the prognosis of this malignancy. We have conducted a detailed population-based study to examine rates of progression of VIN to VSCC, type-specific HPV prevalence in vulvar disease and the influence of HPV status on clinical outcome in VSCC. We observed that the age at which women are diagnosed with VSCC is falling and there is a significant time gap between first diagnosis of VIN and progression to invasive disease. HR-HPV infection was detected in 87{\%} (97/112) cases of VIN and 52{\%} cases (32/62) of VSCC. The presence of HR-HPV in squamous intraepithelial lesion was associated with lower rates of progression to invasive cancer (hazard ratio, 0.22, p=0.001). In the adjusted analysis, HR-HPV was associated with improved progression-free survival of VSCC compared to those with HPV negative tumours (hazard ratio, 0.32, p=0.02).",
keywords = "HPV, human papillomavirus, vulvar intraepithelial neoplasia, vulvar cancer",
author = "Katie Wakeham and Kim Kavanagh and Kate Cuschieri and David Millan and Pollock, {Kevin G} and Sarah Bell and Kevin Burton and Nick Reed and Graham, {Sheila V}",
year = "2016",
month = "10",
day = "7",
language = "English",
pages = "1--35",
journal = "International Journal of Cancer",
issn = "0020-7136",

}

Wakeham, K, Kavanagh, K, Cuschieri, K, Millan, D, Pollock, KG, Bell, S, Burton, K, Reed, N & Graham, SV 2016, 'HPV status and favorable outcome in vulvar squamous cancer', International Journal of Cancer, pp. 1-35.

HPV status and favorable outcome in vulvar squamous cancer. / Wakeham, Katie; Kavanagh, Kim; Cuschieri, Kate; Millan, David; Pollock, Kevin G; Bell, Sarah; Burton, Kevin; Reed, Nick; Graham, Sheila V.

In: International Journal of Cancer, 07.10.2016, p. 1-35.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HPV status and favorable outcome in vulvar squamous cancer

AU - Wakeham, Katie

AU - Kavanagh, Kim

AU - Cuschieri, Kate

AU - Millan, David

AU - Pollock, Kevin G

AU - Bell, Sarah

AU - Burton, Kevin

AU - Reed, Nick

AU - Graham, Sheila V

PY - 2016/10/7

Y1 - 2016/10/7

N2 - It is universally accepted that high-risk human papillomavirus (HR-HPV) is the cause of cervical dysplasia and cancer. More recently it has been shown that HPV is also a marker of clinical outcome in oropharyngeal cancer. However, contemporary information is lacking on both the prevalence of HPV infection in vulvar cancer (VSCC), its precursor lesion, vulvar intraepithelial neoplasia (VIN) and the influence of HPV-status on the prognosis of this malignancy. We have conducted a detailed population-based study to examine rates of progression of VIN to VSCC, type-specific HPV prevalence in vulvar disease and the influence of HPV status on clinical outcome in VSCC. We observed that the age at which women are diagnosed with VSCC is falling and there is a significant time gap between first diagnosis of VIN and progression to invasive disease. HR-HPV infection was detected in 87% (97/112) cases of VIN and 52% cases (32/62) of VSCC. The presence of HR-HPV in squamous intraepithelial lesion was associated with lower rates of progression to invasive cancer (hazard ratio, 0.22, p=0.001). In the adjusted analysis, HR-HPV was associated with improved progression-free survival of VSCC compared to those with HPV negative tumours (hazard ratio, 0.32, p=0.02).

AB - It is universally accepted that high-risk human papillomavirus (HR-HPV) is the cause of cervical dysplasia and cancer. More recently it has been shown that HPV is also a marker of clinical outcome in oropharyngeal cancer. However, contemporary information is lacking on both the prevalence of HPV infection in vulvar cancer (VSCC), its precursor lesion, vulvar intraepithelial neoplasia (VIN) and the influence of HPV-status on the prognosis of this malignancy. We have conducted a detailed population-based study to examine rates of progression of VIN to VSCC, type-specific HPV prevalence in vulvar disease and the influence of HPV status on clinical outcome in VSCC. We observed that the age at which women are diagnosed with VSCC is falling and there is a significant time gap between first diagnosis of VIN and progression to invasive disease. HR-HPV infection was detected in 87% (97/112) cases of VIN and 52% cases (32/62) of VSCC. The presence of HR-HPV in squamous intraepithelial lesion was associated with lower rates of progression to invasive cancer (hazard ratio, 0.22, p=0.001). In the adjusted analysis, HR-HPV was associated with improved progression-free survival of VSCC compared to those with HPV negative tumours (hazard ratio, 0.32, p=0.02).

KW - HPV

KW - human papillomavirus

KW - vulvar intraepithelial neoplasia

KW - vulvar cancer

UR - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215

M3 - Article

SP - 1

EP - 35

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

ER -

Wakeham K, Kavanagh K, Cuschieri K, Millan D, Pollock KG, Bell S et al. HPV status and favorable outcome in vulvar squamous cancer. International Journal of Cancer. 2016 Oct 7;1-35.